4CPS-264 Population pharmacokinetic model of etanercept in rheumatic disease: prognostic factors and dose recommendations

BACKGROUND: Etanercept is an approved monoclonal antibody for the treatment of rheumatic disease (RD). Individual clinical response to etanercept can be influenced by their pharmacokinetics (PK) and immunogenicity, so therapeutic drug monitoring (TDM) can guide these biologic treatments. PURPOSE: De...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hosp Pharm
Main Authors: Sanchez-Hernandez, JG, Pérez-Blanco, JS, Beunza-Sola, M, Rebollo-Diaz, N, Saez-Fernandez, EM, Laso-Lucas, E, Rodriguez-Cajaraville, L, Calvo, MV
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Group 2018
Fag:
Section 4: Clinical pharmacy services
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535412/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.354
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker